Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
A new study has identified genes that, when inhibited, may slow or stop the progression of primary effusion lymphoma.
A team of scientists developed a novel stem cell model to demonstrate that a pathway that protects against herpes simplex virus 1 infection is unique to neurons in the brain.
A study published in the journal Cell uncovers how poxviruses take control of a protein complex in order to enhance their replication and counteract an immune response in hosts.
Samantha Genardi, a fourth-year student in the Driskill Graduate Program (DGP), studies cell response to bacterial infection in the laboratory of Chyung-Ru Wang, PhD, professor of Microbiology-Immunology.
Mutations in a gene called DBR1 may increase patients’ susceptibility to brain infection, according to a study published in Cell.
A new study advances the understanding of how human cytomegalovirus replicates within cells and also reveals potential treatment targets for the common virus.
Northwestern Medicine scientists have discovered a protein that acts as an entry point for the Epstein-Barr virus, providing a potential target for future therapies.
Northwestern Medicine scientists showed how enzyme inhibitors might be used to halt a molecular process that can cause neurodegeneration in patients with HIV.
A newly-designed mutant herpes virus provides a strategy for the development of novel herpes virus vaccines.